Triptans other than sumatriptan in child and adolescent migraine: Literature review

Research output: Contribution to journalArticle

Abstract

Abortive drugs used for migraine in children and adolescents are usually the same as those used in adults. Only a few studies have assessed the efficacy of triptans other than sumatriptan in pediatric migraine. This systematic review describes the evidence concerning the efficacy and tolerability of these triptans. The PubMed research produced 481 results and only seven studies were randomized controlled trials. A total of 11 articles were reviewed. Zolmitriptan and rizatriptan were superior to placebo in most studies. Almotriptan demonstrated a high profile of tolerability. A single study of eletriptan demonstrated no statistical difference between this drug and placebo in terms of both efficacy and tolerability. All studies have reported a good triptan safety profile. The conflicting data regarding triptan efficacy are probably due to differences in populations, methodologies and efficacy measures among the different studies. Triptans are an important option in the symptomatic treatment of childhood and adolescent migraine.

Original languageEnglish
Pages (from-to)395-401
Number of pages7
JournalExpert Review of Neurotherapeutics
Volume11
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Tryptamines
Sumatriptan
Migraine Disorders
zolmitriptan
Placebos
PubMed
Pharmaceutical Preparations
Randomized Controlled Trials
Pediatrics
Safety
Research
Population

Keywords

  • zolmitriptan

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology (medical)

Cite this

@article{811edd01b99d4d7e91112bf4d17fcdbd,
title = "Triptans other than sumatriptan in child and adolescent migraine: Literature review",
abstract = "Abortive drugs used for migraine in children and adolescents are usually the same as those used in adults. Only a few studies have assessed the efficacy of triptans other than sumatriptan in pediatric migraine. This systematic review describes the evidence concerning the efficacy and tolerability of these triptans. The PubMed research produced 481 results and only seven studies were randomized controlled trials. A total of 11 articles were reviewed. Zolmitriptan and rizatriptan were superior to placebo in most studies. Almotriptan demonstrated a high profile of tolerability. A single study of eletriptan demonstrated no statistical difference between this drug and placebo in terms of both efficacy and tolerability. All studies have reported a good triptan safety profile. The conflicting data regarding triptan efficacy are probably due to differences in populations, methodologies and efficacy measures among the different studies. Triptans are an important option in the symptomatic treatment of childhood and adolescent migraine.",
keywords = "zolmitriptan",
author = "Catello Vollono and Federico Vigevano and Samuela Tarantino and Massimiliano Valeriani",
year = "2011",
month = "3",
doi = "10.1586/ern.10.147",
language = "English",
volume = "11",
pages = "395--401",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Triptans other than sumatriptan in child and adolescent migraine

T2 - Literature review

AU - Vollono, Catello

AU - Vigevano, Federico

AU - Tarantino, Samuela

AU - Valeriani, Massimiliano

PY - 2011/3

Y1 - 2011/3

N2 - Abortive drugs used for migraine in children and adolescents are usually the same as those used in adults. Only a few studies have assessed the efficacy of triptans other than sumatriptan in pediatric migraine. This systematic review describes the evidence concerning the efficacy and tolerability of these triptans. The PubMed research produced 481 results and only seven studies were randomized controlled trials. A total of 11 articles were reviewed. Zolmitriptan and rizatriptan were superior to placebo in most studies. Almotriptan demonstrated a high profile of tolerability. A single study of eletriptan demonstrated no statistical difference between this drug and placebo in terms of both efficacy and tolerability. All studies have reported a good triptan safety profile. The conflicting data regarding triptan efficacy are probably due to differences in populations, methodologies and efficacy measures among the different studies. Triptans are an important option in the symptomatic treatment of childhood and adolescent migraine.

AB - Abortive drugs used for migraine in children and adolescents are usually the same as those used in adults. Only a few studies have assessed the efficacy of triptans other than sumatriptan in pediatric migraine. This systematic review describes the evidence concerning the efficacy and tolerability of these triptans. The PubMed research produced 481 results and only seven studies were randomized controlled trials. A total of 11 articles were reviewed. Zolmitriptan and rizatriptan were superior to placebo in most studies. Almotriptan demonstrated a high profile of tolerability. A single study of eletriptan demonstrated no statistical difference between this drug and placebo in terms of both efficacy and tolerability. All studies have reported a good triptan safety profile. The conflicting data regarding triptan efficacy are probably due to differences in populations, methodologies and efficacy measures among the different studies. Triptans are an important option in the symptomatic treatment of childhood and adolescent migraine.

KW - zolmitriptan

UR - http://www.scopus.com/inward/record.url?scp=79952692181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952692181&partnerID=8YFLogxK

U2 - 10.1586/ern.10.147

DO - 10.1586/ern.10.147

M3 - Article

C2 - 21375444

AN - SCOPUS:79952692181

VL - 11

SP - 395

EP - 401

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 3

ER -